Marksans Pharma consolidated net profit rises 25.61% in the December 2024 quarter
Net profit of Marksans Pharma rose 25.61% to Rs 104.56 crore in the quarter ended December 2024 as against Rs 83.24 crore during the previous quarter ended December 2023. Sales rose 16.33% to Rs 681.85 crore in the quarter ended December 2024 as against Rs 586.13 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended | ||
| Dec. 2024 | Dec. 2023 | % Var. | |
| Sales | 681.85 | 586.13 | 16 |
| OPM % | 20.35 | 22.69 | - |
| PBDT | 163.95 | 134.66 | 22 |
| PBT | 143.26 | 112.66 | 27 |
| NP | 104.56 | 83.24 | 26 |
